Carlos A. Cañas

Serious liver disease induced by infliximab

Gabriel J. Tobón, Carlos A. Cañas, Juan-Jose Jaller et al. · Clinical Rheumatology · 2006 · 160 citations

Veterinary Medicine, Internal Medicine, Pharmacotherapy +12

Current Understanding and Management of Chronic Hepatosplenic Suppurative Brucellosis

Javier Ariza, Carlos Pigrau, Carlos A. Cañas et al. · Clinical Infectious Diseases · 2001 · 139 citations · Full text

Medicine, Infectious Diseases, Pathology +12

The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals

Carlos A. Cañas · Medical Hypotheses · 2020 · 109 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Diffuse alveolar hemorrhage in Colombian patients with systemic lupus erythematosus

Carlos A. Cañas, Gabriel J. Tobón, Marcela Granados et al. · Clinical Rheumatology · 2007 · 69 citations

Medicine, Internal Medicine, Pathology +9

Efficacy and Safety of Anti–Interleukin 6 Receptor Monoclonal Antibody (Tocilizumab) in Colombian Patients With Takayasu Arteritis

Carlos A. Cañas, Felipe Cañas, Jorge Hernán Izquierdo et al. · JCR Journal of Clinical Rheumatology · 2014 · 54 citations

Life Sciences, Clinical Sciences, Pharmacotherapy +12